Chimeric Antigen Receptor | CHOP Research Institute

Chimeric Antigen Receptor

Published on
Feb 22, 2023
Cassie Kline, MD, MAS, and Jessica Foster, MD, received a seed grant to study CAR T-cell and radiotherapy for diffuse midline gliomas.
Published on
May 23, 2022
Neuro-oncologist Jessica Foster MD, is investigating chimeric antigen receptor (CAR) T-cell therapy for brain tumors.

Dr. Richman's research focuses on chimeric antigen receptor (CAR) T cells targeting solid tumors with the goal of translating these findings to this unmet clinical need.

richmans [at]
Published on
Aug 31, 2017
It was a pivotal moment that has turned into a new era for cancer immunotherapy. On April 17, 2012, Children's Hospital of Philadelphia researchers for the first time treated a pediatric patient with a cellular therapy that used her own reprogrammed immune cells, called T cells, to attack her aggressive form of blood cancer.
Published on
Jan 27, 2017
Super Bowl Sunday is right around the corner, and our biweekly installment of In the News is the perfect playing field for us to showcase the wide range of research projects that Children's Hospital of Philadelphia experts tackle. Huddle up!
Published on
May 8, 2015
Cookies for Kids’ Cancer, a nonprofit foundation dedicated to pediatric cancer research, uses the proceeds from its cookie sales and other fundraising events to provide grants to support the work of scientists at five of the nation’s leading pediatric cancer centers.